Neuronal Mechanisms of Human Episodic Memory

NCT04500119 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-02-09

No results posted yet for this study

Summary

The purpose the research is to better understand how the human brain accomplishes the basic cognitive tasks of learning new information, recalling stored information, and making decisions or choices about presented information. These investigations are critical to better understand human cognition and to design treatments for disorders of learning and memory.

Conditions

  • Epilepsy Intractable

Interventions

BEHAVIORAL

Cedrus RB-844 response pad; Adtech Behnke-Fried micro-electrodes; Neurolynx electrophysiology system; Blackrock Cerestim stimulator

Devices listed are components of a single intervention that includes: Record patient responses (Cedrus RB-844), record neuronal activity (Neurolynx) from electrodes (Adtech Behnke-Fried), apply intermittent electrical stimulation (Blackrock Cerestim)

Sponsors & Collaborators

  • Johns Hopkins University

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • University Health Network, Toronto

    collaborator OTHER
  • Boston Children's Hospital

    collaborator OTHER
  • University of California, Santa Barbara

    collaborator OTHER
  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • California Institute of Technology

    collaborator OTHER
  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Ueli Rutishauser, PhD · Cedars-Sinai Medical Center

  • Adam Mamelak, MD · Cedars-Sinai Medical Center

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-12
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04500119 on ClinicalTrials.gov